12 results on '"Maurizi P"'
Search Results
2. Patient-Reported Outcomes and Return to Intended Oncologic Therapy After Colorectal Enhanced Recovery Pathway
- Author
-
The Italian ColoRectal Anastomotic Leakage (iCral3) study group, Marco Catarci, MD, FACS, Giacomo Ruffo, MD, Massimo Giuseppe Viola, MD, Ferdinando Ficari, MD, Paolo Delrio, MD, Felice Pirozzi, MD, Felice Borghi, MD, Raffaele De Luca, MD, Alberto Patriti, MD, Gianluca Garulli, MD, Walter Siquini, MD, Stefano D’Ugo, MD, PhD, FEBS, FACS, Stefano Scabini, MD, Marco Caricato, MD, FACS, Giusto Pignata, MD, Andrea Liverani, MD, Roberto Campagnacci, MD, Pierluigi Marini, MD, Ugo Elmore, MD, Francesco Corcione, MD, Roberto Santoro, MD, Massimo Carlini, MD, FACS, Antonio Giuliani, MD, Mario Sorrentino, MD, Giovanni Ferrari, MD, Gianandrea Baldazzi, MD, Alberto Di Leo, MD, Augusto Verzelli, MD, Giuseppe Sica, MD, Stefano Rausei, MD, Davide Cavaliere, MD, Gian Luca Baiocchi, MD, FACS, Marco Milone, MD, Giovanni Ciaccio, MD, Giovanni Domenico Tebala, MD, FACS, FRCS, Marco Scatizzi, MD, Luigi Boni, MD, FACS, Stefano Mancini, MD, Mario Guerrieri, MD, Roberto Persiani, MD, Andrea Lucchi, MD, FACS, Dario Parini, MD, Antonino Spinelli, MD, Michele Genna, MD, Vincenzo Bottino, MD, Andrea Coratti, MD, Dario Scala, MD, Andrea Muratore, MD, Maurizio Pavanello, MD, Umberto Rivolta, MD, Micaela Piccoli, MD, FACS, Carlo Talarico, MD, Alessandro Carrara, MD, Stefano Guadagni, MD, Mauro Totis, MD, Franco Roviello, MD, Alessandro Anastasi, MD, Gianluca Guercioni, MD, Giuseppe Maria Ettorre, MD, Mauro Montuori, MD, Pierpaolo Mariani, MD, Nicolò de Manzini, MD, Annibale Donini, MD, Mariano Fortunato Armellino, MD, Lucio Taglietti, MD, Gabriele Anania, MD, Mariantonietta Di Cosmo, MD, Carlo Vittorio Feo, MD, Paolo Millo, MD, Corrado Pedrazzani, MD, Silvio Guerriero, MD, Andrea Costanzi, MD, Nereo Vettoretto, MD, Federico Marchesi, MD, Massimo Basti, MD, Graziano Longo, MD, Moreno Cicetti, MD, Paolo Ciano, MD, Michele Benedetti, MD, Leonardo Antonio Montemurro, MD, Maria Sole Mattei, MD, Elena Belloni, MD, Elisa Bertocchi, MD, Gaia Masini, MD, Amedeo Altamura, MD, Francesco Rubichi, MD, Francesco Giudici, MD, Fabio Cianchi, MD, Gabriele Baldini, MD, Ugo Pace, MD, Andrea Fares Bucci, MD, Antonio Sciuto, MD, Desirée Cianflocca, MD, Marco Migliore, MD, Michele Simone, MD, Marcella Lodovica Ricci, MD, Francesco Monari, MD, Alessandro Cardinali, MD, Massimo Sartelli, MD, Marcello Spampinato, MD, PhD, FEBS (HPB), Alessandra Aprile, MD, Domenico Soriero, MD, Gabriella Teresa Capolupo, MD, FACS, Jacopo Andreuccetti, MD, Ilaria Canfora, MD, Andrea Scarinci, MD, Angela Maurizi, MD, Grazia Maria Attinà, MD, Giulia Maggi, MD, Umberto Bracale, MD, Roberto Peltrini, MD, Pietro Amodio, MD, Domenico Spoletini, MD, PhD, FACS, Rosa Marcellinaro, MD, Giovanni Del Vecchio, MD, Massimo Stefanoni, MD, Carmelo Magistro, MD, Diletta Cassini, MD, Lorenzo Crepaz, MD, Andrea Budassi, MD, Bruno Sensi, MD, Silvia Tenconi, MD, Leonardo Solaini, MD, Giorgio Ercolani, MD, Sarah Molfino, MD, Giovanni Domenico De Palma, MD, Paolo Locurto, MD, Antonio Di Cintio, MD, Lorenzo Pandolfini, MD, Alessandro Falsetto, MD, Elisa Cassinotti, MD, Andrea Sagnotta, MD, PhD, Monica Ortenzi, MD, Alberto Biondi, MD, Giacomo Martorelli, MD, Maurizio De Luca, MD, Francesco Carrano, MD, Annalisa Maroli, PhD, Francesca Fior, MD, Antonio Ferronetti, MD, Giuseppe Giuliani, MD, Roberto Benigni, MD, Graziella Marino, MD, Patrizia Marsanic, MD, Nicoletta Sveva Pipitone Federico, MD, Carlo Di Marco, MD, Camillo Leonardo Bertoglio, MD, PhD, Francesca Pecchini, MD, Vincenzo Greco, MD, Michele Motter, MD, Giuseppe Tirone, MD, Marco Clementi, MD, Nicolò Tamini, MD, Riccardo Piagnerelli, MD, Giuseppe Canonico, MD, Simone Cicconi, MD, Marco Colasanti, MD, Enrico Pinotti, MD, Roberta Carminati, MD, Edoardo Osenda, MD, Luigina Graziosi, MD, Ciro De Martino, MD, Giovanna Ioia, MD, Arianna Birindelli, MD, Matteo Chiozza, MD, Daniele Zigiotto, MD, Fioralba Pindozzi, MD, Manuela Grivon, MD, Cristian Conti, MD, Lorenzo Organetti, MD, Michela Monteleone, MD, Emanuele Botteri, MD, Giorgio Dalmonte, MD, Diletta Frazzini, MD, Simone Santoni, MD, Gabriele La Gioia, MD, and Diana Giannarelli, MS, PhD
- Subjects
Surgery ,RD1-811 - Abstract
Objective:. To evaluate the influence of enhanced recovery pathway (ERP) on patient-reported outcome measures (PROMs) and return to intended oncologic therapy (RIOT) after colorectal surgery. Background:. ERP improves early outcomes after colorectal surgery; however, little is known about its influence on PROMs and on RIOT. Methods:. Prospective multicenter enrollment of patients who underwent colorectal resection with anastomosis was performed, recording variables related to patient-, institution-, procedure-level data, adherence to the ERP, and outcomes. The primary endpoints were PROMs (administered before surgery, at discharge, and 6 to 8 weeks after surgery) and RIOT after surgery for malignancy, defined as the intended oncologic treatment according to national guidelines and disease stage, administered within 8 weeks from the index operation, evaluated through multivariate regression models. Results:. The study included 4529 patients, analyzed for PROMs, 1467 of which were analyzed for RIOT. Compared to their baseline preoperative values, all PROMs showed significant worsening at discharge and improvement at late evaluation. PROMs values at discharge and 6 to 8 weeks after surgery, adjusted through a generalized mixed regression model according to preoperative status and other variables, showed no association with ERP adherence rates. RIOT rates (overall 54.5%) were independently lower by aged > 69 years, ASA Class III, open surgery, and presence of major morbidity; conversely, they were independently higher after surgery performed in an institutional ERP center and by ERP adherence rates > median (69.2%). Conclusions:. Adherence to the ERP had no effect on PROMs, whereas it independently influenced RIOT rates after surgery for colorectal cancer.
- Published
- 2023
- Full Text
- View/download PDF
3. The ChoCO-W prospective observational global study: Does COVID-19 increase gangrenous cholecystitis?
- Author
-
De Simone, Belinda, Abu-Zidan, Fikri M., Chouillard, Elie, Di Saverio, Salomone, Sartelli, Massimo, Podda, Mauro, Gomes, Carlos Augusto, Moore, Ernest E., Moug, Susan J., Ansaloni, Luca, Kluger, Yoram, Coccolini, Federico, Landaluce-Olavarria, Aitor, Estraviz-Mateos, Begoña, Uriguen-Etxeberria, Ana, Giordano, Alessio, Luna, Alfonso Palmieri, Amín, Luz Adriana Hernández, Hernández, Adriana María Palmieri, Shabana, Amanda, Dzulkarnaen, Zakaria Andee, Othman, Muhammad Asyraf, Sani, Mohamad Ikhwan, Balla, Andrea, Scaramuzzo, Rosa, Lepiane, Pasquale, Bottari, Andrea, Staderini, Fabio, Cianchi, Fabio, Cavallaro, Andrea, Zanghì, Antonio, Cappellani, Alessandro, Campagnacci, Roberto, Maurizi, Angela, Martinotti, Mario, Ruggieri, Annamaria, Jusoh, Asri Che, Rahman, Karim Abdul, Zulkifli, Anis Suraya M., Petronio, Barbara, Matías-García, Belén, Quiroga-Valcárcel, Ana, Mendoza-Moreno, Fernando, Atanasov, Boyko, Campanile, Fabio Cesare, Vecchioni, Ilaria, Cardinali, Luca, Travaglini, Grazia, Sebastiani, Elisa, Chooklin, Serge, Chuklin, Serhii, Cianci, Pasquale, Restini, Enrico, Capuzzolo, Sabino, Currò, Giuseppe, Filippo, Rosalinda, Rispoli, Michele, Aparicio-Sánchez, Daniel, Muñóz-Cruzado, Virginia Durán, Barbeito, Sandra Dios, Delibegovic, Samir, Kesetovic, Amar, Sasia, Diego, Borghi, Felice, Giraudo, Giorgio, Visconti, Diego, Doria, Emanuele, Santarelli, Mauro, Luppi, Davide, Bonilauri, Stefano, Grossi, Ugo, Zanus, Giacomo, Sartori, Alberto, Piatto, Giacomo, De Luca, Maurizio, Vita, Domenico, Conti, Luigi, Capelli, Patrizio, Cattaneo, Gaetano Maria, Marinis, Athanasios, Vederaki, Styliani-Aikaterini, Bayrak, Mehmet, Altıntas, Yasemin, Uzunoglu, Mustafa Yener, Demirbas, Iskender Eren, Altinel, Yuksel, Meric, Serhat, Aktimur, Yunus Emre, Uymaz, Derya Salim, Omarov, Nail, Azamat, Ibrahim, Lostoridis, Eftychios, Nagorni, Eleni-Aikaterini, Pujante, Antonio, Anania, Gabriele, Bombardini, Cristina, Bagolini, Francesco, Gonullu, Emre, Mantoglu, Baris, Capoglu, Recayi, Cappato, Stefano, Muzio, Elena, Colak, Elif, Polat, Suleyman, Koylu, Zehra Alan, Altintoprak, Fatih, Bayhan, Zülfü, Akin, Emrah, Andolfi, Enrico, Rezart, Sulce, Kim, Jae Il, Jung, Sung Won, Shin, Yong Chan, Enciu, Octavian, Toma, Elena Adelina, Medas, Fabio, Canu, Gian Luigi, Cappellacci, Federico, D’Acapito, Fabrizio, Ercolani, Giorgio, Solaini, Leonardo, Roscio, Francesco, Clerici, Federico, Gelmini, Roberta, Serra, Francesco, Rossi, Elena Giulia, Fleres, Francesco, Clarizia, Guglielmo, Spolini, Alessandro, Ferrara, Francesco, Nita, Gabriela, Sarnari, Jlenia, Gachabayov, Mahir, Abdullaev, Abakar, Poillucci, Gaetano, Palini, Gian Marco, Veneroni, Simone, Garulli, Gianluca, Piccoli, Micaela, Pattacini, Gianmaria Casoni, Pecchini, Francesca, Argenio, Giulio, Armellino, Mariano Fortunato, Brisinda, Giuseppe, Tedesco, Silvia, Fransvea, Pietro, Ietto, Giuseppe, Franchi, Caterina, Carcano, Giulio, Martines, Gennaro, Trigiante, Giuseppe, Negro, Giulia, Vega, Gustavo Machain, González, Agustín Rodríguez, Ojeda, Leonardo, Piccolo, Gaetano, Bondurri, Andrea, Maffioli, Anna, Guerci, Claudio, Sin, Boo Han, Zuhdi, Zamri, Azman, Azlanudin, Mousa, Hussam, al Bahri, Shadi, Augustin, Goran, Romic, Ivan, Moric, Trpimir, Nikolopoulos, Ioannis, Andreuccetti, Jacopo, Pignata, Giusto, D’Alessio, Rossella, Kenig, Jakub, Skorus, Urszula, Fraga, Gustavo Pereira, Hirano, Elcio Shiyoiti, de Lima Bertuol, Jackson Vinícius, Isik, Arda, Kurnaz, Eray, Asghar, Mohammad Sohail, Afzal, Ameer, Akbar, Ali, Nikolouzakis, Taxiarchis Konstantinos, Lasithiotakis, Konstantinos, Chrysos, Emmanuel, Das, Koray, Özer, Nazmi, Seker, Ahmet, Ibrahim, Mohamed, Hamid, Hytham K. S., Babiker, Ahmed, Bouliaris, Konstantinos, Koukoulis, George, Kolla, Chrysoula-Christina, Lucchi, Andrea, Agostinelli, Laura, Taddei, Antonio, Fortuna, Laura, Agostini, Carlotta, Licari, Leo, Viola, Simona, Callari, Cosimo, Laface, Letizia, Abate, Emmanuele, Casati, Massimiliano, Anastasi, Alessandro, Canonico, Giuseppe, Gabellini, Linda, Tosi, Lorenzo, Guariniello, Anna, Zanzi, Federico, Bains, Lovenish, Sydorchuk, Larysa, Iftoda, Oksana, Sydorchuk, Andrii, Malerba, Michele, Costanzo, Federico, Galleano, Raffaele, Monteleone, Michela, Costanzi, Andrea, Riva, Carlo, Walędziak, Maciej, Kwiatkowski, Andrzej, Czyżykowski, Łukasz, Major, Piotr, Strzałka, Marcin, Matyja, Maciej, Natkaniec, Michal, Valenti, Maria Rosaria, Di Vita, Maria Domenica Pia, Sotiropoulou, Maria, Kapiris, Stylianos, Massalou, Damien, Veroux, Massimiliano, Volpicelli, Alessio, Gioco, Rossella, Uccelli, Matteo, Bonaldi, Marta, Olmi, Stefano, Nardi, Matteo, Livadoti, Giada, Mesina, Cristian, Dumitrescu, Theodor Viorel, Ciorbagiu, Mihai Calin, Ammendola, Michele, Ammerata, Giorgio, Romano, Roberto, Slavchev, Mihail, Misiakos, Evangelos P., Pikoulis, Emmanouil, Papaconstantinou, Dimitrios, Elbahnasawy, Mohamed, Abdel-elsalam, Sherief, Felsenreich, Daniel M., Jedamzik, Julia, Michalopoulos, Nikolaos V., Sidiropoulos, Theodoros A., Papadoliopoulou, Maria, Cillara, Nicola, Deserra, Antonello, Cannavera, Alessandro, Negoi, Ionuţ, Schizas, Dimitrios, Syllaios, Athanasios, Vagios, Ilias, Gourgiotis, Stavros, Dai, Nick, Gurung, Rekha, Norrey, Marcus, Pesce, Antonio, Feo, Carlo Vittorio, Fabbri, Nicolo’, Machairas, Nikolaos, Dorovinis, Panagiotis, Keramida, Myrto D., Mulita, Francesk, Verras, Georgios Ioannis, Vailas, Michail, Yalkin, Omer, Iflazoglu, Nidal, Yigit, Direnc, Baraket, Oussama, Ayed, Karim, Ghalloussi, Mohamed hedi, Patias, Parmenion, Ntokos, Georgios, Rahim, Razrim, Bala, Miklosh, Kedar, Asaf, Sawyer, Robert G., Trinh, Anna, Miller, Kelsey, Sydorchuk, Ruslan, Knut, Ruslan, Plehutsa, Oleksandr, Liman, Rumeysa Kevser, Ozkan, Zeynep, Kader, Saleh Abdel, Gupta, Sanjay, Gureh, Monika, Saeidi, Sara, Aliakbarian, Mohsen, Dalili, Amin, Shoko, Tomohisa, Kojima, Mitsuaki, Nakamoto, Raira, Atici, Semra Demirli, Tuncer, Gizem Kilinc, Kaya, Tayfun, Delis, Spiros G., Rossi, Stefano, Picardi, Biagio, del Monte, Simone Rossi, Triantafyllou, Tania, Theodorou, Dimitrios, Pintar, Tadeja, Salobir, Jure, Manatakis, Dimitrios K., Tasis, Nikolaos, Acheimastos, Vasileios, Ioannidis, Orestis, Loutzidou, Lydia, Symeonidis, Savvas, de Sá, Tiago Correia, Rocha, Mónica, Guagni, Tommaso, Pantalone, Desiré, Maltinti, Gherardo, Khokha, Vladimir, Abdel-elsalam, Wafaa, Ghoneim, Basma, López-Ruiz, José Antonio, Kara, Yasin, Zainudin, Syaza, Hayati, Firdaus, Azizan, Nornazirah, Khei, Victoria Tan Phooi, Yi, Rebecca Choy Xin, Sellappan, Harivinthan, Demetrashvili, Zaza, Lekiashvili, Nika, Tvaladze, Ana, Froiio, Caterina, Bernardi, Daniele, Bonavina, Luigi, Gil-Olarte, Angeles, Grassia, Sebastiano, Romero-Vargas, Estela, Bianco, Francesco, Gumbs, Andrew A., Dogjani, Agron, Agresta, Ferdinando, Litvin, Andrey, Balogh, Zsolt J., Gendrikson, George, Martino, Costanza, Damaskos, Dimitrios, Pararas, Nikolaos, Kirkpatrick, Andrew, Kurtenkov, Mikhail, Gomes, Felipe Couto, Pisanu, Adolfo, Nardello, Oreste, Gambarini, Fabrizio, Aref, Hager, Angelis, Nicola de’, Agnoletti, Vanni, Biondi, Antonio, Vacante, Marco, Griggio, Giulia, Tutino, Roberta, Massani, Marco, Bisetto, Giovanni, Occhionorelli, Savino, Andreotti, Dario, Lacavalla, Domenico, Biffl, Walter L., and Catena, Fausto
- Published
- 2022
- Full Text
- View/download PDF
4. Adjuvant chemotherapy, extent of resection, and immunoistochemical neuroendocrine markers as prognostic factors of early‐stage large‐cell neuroendocrine carcinoma
- Author
-
Claudio Andreetti, Mohsen Ibrahim, Antonio Gagliardi, Camilla Poggi, Giulio Maurizi, Domenico Armillotta, Valentina Peritone, Leonardo Teodonio, Erino Angelo Rendina, Federico Venuta, Marco Anile, Giovanni Natale, Mario Santini, and Alfonso Fiorelli
- Subjects
adjuvant chemotherapy ,immunoistochemical neuroendocrine markers ,large‐cell neuroendocrine carcinoma ,lobectomy ,surgery ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background We investigated whether adjuvant chemotherapy, extent of resection, and immunoistochemical neuroendocrine markers affected survival of patients with the early stage of large‐cell neuroendocrine cancer. Methods This was a retrospective multicenter study including consecutive patients undergoing resection of node negative large‐cell neuroendocrine carcinoma. Five‐year survival and disease‐free survival rate were evaluated by the Kaplan–Meier method and the log‐rank test in relation to adjuvant chemotherapy, extent of resection, and immunoistochemical neuroendocrine markers (synaptophysin, chromogranin A, and neuron‐specific enolase). Results Our study population included 117 patients; 47 (40%) of these received adjuvant chemotherapy. Patients treated with adjuvant chemotherapy had better survival (74% vs. 45%, p = 0.002) and disease‐free survival (79% vs. 40%, p = 0.001) in all cases except patients with tumor 20 mm.
- Published
- 2022
- Full Text
- View/download PDF
5. The use of Transcollation Technology for Video-Assisted Thoracic Surgery lobectomy
- Author
-
Cecilia Menna, Camilla Poggi, Claudio Andreetti, Anna Maria Ciccone, Alberto Emiliano Baccarini, Giulio Maurizi, Antonio D’Andrilli, Camilla Vanni, Roberto Cascone, Alfonso Fiorelli, Mario Santini, Federico Venuta, Erino Angelo Rendina, and Mohsen Ibrahim
- Subjects
Transcollation technology ,Bipolar sealer ,VATS lobectomy ,Hilar dissection ,Blood loss reduction ,Surgery ,RD1-811 ,Anesthesiology ,RD78.3-87.3 - Abstract
Abstract Background Video-Assisted Thoracic Surgery (VATS) lobectomy is now considered the preferred approach at many centers for early stage lung cancer. However, it needs an adequate learning curve, and it may be challenging in non-expert hands. The aim of this study was to evaluate the effectiveness of Transcollation Technology over Traditional Electrocautery to perform hilar and mediastinal dissection during VATS lobectomy. Methods This is a single-center retrospective study including consecutive patients undergoing VATS lobectomy for lung cancer. Patients were divided in two groups based on whether Transcollation Technology (TT Group) or Traditional Electrocautery (TE Group) was used for hilar and mediastinal lymphadenectomy. Operative time and surgical outcome, including number of transfusions, length of chest drainage, length of hospital stay, morbidity and mortality were registered, and the inter-group differences were statistically analyzed. Results 53 patients were included in the final analysis. The TT Group (n = 24) compared to the TE Group (n = 29) showed significant shorter operative time (75.2 ± 25.8 min versus 98.1 ± 33.3 min; p = 0.023), and reduction of length of chest tube stay (4.7 ± 0.8 days vs. 6.8 ± 1.1 days, p = 0.013) and length of hospital stay (5.3 ± 1.9 days vs. 6.8 ± 1.1 days, p = 0.007). No intraoperative or major postoperative complications were observed in either groups. Conclusions Transcollation Technology represents a valid alternative to standard electrocautery instruments during VATS lobectomy. It contributes to reduce the operative time and length of hospital stay. Further larger prospective studies are required to confirm our data.
- Published
- 2020
- Full Text
- View/download PDF
6. Surgical treatment of lung cancer with adjacent lobe invasion in relation to fissure integrity
- Author
-
Claudio Andreetti, Camilla Poggi, Mohsen Ibrahim, Antonio D'Andrilli, Giulio Maurizi, Matteo Tiracorrendo, Valentina Peritore, Erino Angelo Rendina, Federico Venuta, Marco Anile, Andreina Pagini, Giovanni Natale, Mario Santini, and Alfonso Fiorelli
- Subjects
Adjacent lobe ,fissure integrity ,lung cancer ,pleural invasion ,surgery ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background Tumor with adjacent lobe invasion (T‐ALI) is an uncommon condition. Controversy still exists regarding the optimal resection of adjacent lobe invasion, and the prognostic value in relation to fissure integrity at the tumor invasion point. The aims of this paper were to evaluate the prognosis of T‐ALI with regard to fissure integrity, and type of resection. Methods This was a retrospective multicenter study which included all consecutive patients with T‐ALI undergoing surgical treatment. Based on radiological, intraoperative and histological findings, T‐ALI patients were differentiated into two groups based on whether the fissure was complete (T‐ALI‐A group) or incomplete (T‐ALI‐D Group) at the level of tumor invasion point. Clinico‐pathological features and survival of two study groups were analyzed and compared. Results Study population included 135 patients, of these 98 (72%) were included into T‐ALI‐A group, and 37 (38%) into T‐ALI‐D Group. T‐ALI‐D patients had better overall survival than T‐ALI‐A patients (63.9 ± 7.0 vs. 48.9 ± 3.9; respectively, P = 0.01) who presented with a higher incidence of lymph node involvement (35% vs. 4%; P = 0.004), and recurrence rate (43% vs. 16%; P = 0.01). At multivariable analysis, T‐ALI‐D (P = 0.01), pN0 stage (P = 0.0002), and pT≤5 cm (P = 0.0001) were favorable survival prognostic factors. Conclusions T‐ALI‐D presented a better prognosis than T‐ALI‐A while extent of resection had no effect on survival. Thus, in patients with small T‐ALI‐D and without lymph node involvement, sublobar resection of adjacent lobe rather than lobectomy could be indicated. Key points The extent of resection of adjacent lobe had no effect on survival while T‐ALI‐D, pN0 stage, and pT≤5 cm were significant prognostic factors. In patients with small T‐ALI‐D and without lymph node involvement, sublobar resection of adjacent lobe could be indicated as an alternative to lobectomy.
- Published
- 2020
- Full Text
- View/download PDF
7. Multimodal treatment of pediatric patients with Askin’s tumors: our experience
- Author
-
Silvia Triarico, Giorgio Attinà, Palma Maurizi, Stefano Mastrangelo, Lorenzo Nanni, Vito Briganti, Elisa Meacci, Stefano Margaritora, Mario Balducci, and Antonio Ruggiero
- Subjects
Askin’s tumors ,Thoracopulmonary region ,Polychemotherapy ,Radiotherapy ,Surgery ,RD1-811 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background We report our experience and outcomes about the management of Askin’s tumors [AT], which are rare primitive neuroectodermal tumors (PNETs) that develop within the soft tissue of the thoracopulmonary region, typically in children and adolescents. Methods We retrospectively analyzed the charts of 9 patients affected by AT (aged 6–15 years), treated at the Paediatric Oncology Unit of Gemelli University Hospital in Rome between January 2001 and December 2016. Results All nine patients underwent to biopsy followed by neoadjuvant chemotherapy. At the end of the neoadjuvant chemotherapy, they underwent to surgical removal of the residual tumor. Five patients with positive tumor margins and/or necrosis
- Published
- 2018
- Full Text
- View/download PDF
8. Multimodal treatment of pediatric patients with Askin’s tumors: our experience
- Author
-
Triarico, Silvia, Attinà, Giorgio, Maurizi, Palma, Mastrangelo, Stefano, Nanni, Lorenzo, Briganti, Vito, Meacci, Elisa, Margaritora, Stefano, Balducci, Mario, and Ruggiero, Antonio
- Published
- 2018
- Full Text
- View/download PDF
9. Intravitreal Injection of Dexamethasone Implant and Ranibizumab in Cystoid Macular Edema in the Course of Irvine-Gass Syndrome
- Author
-
Vito Fenicia, Marco Balestrieri, Andrea Perdicchi, Maurizio Maurizi Enrici, Martina Delle Fave, and Santi Maria Recupero
- Subjects
Irvine-Gass syndrome ,Cystoid macular edema ,Intravitreal injection ,Dexamethasone ,Ranibizumab ,Cataract ,Surgery ,Complication ,Ophthalmology ,RE1-994 - Abstract
Purpose: To evaluate the efficacy of 2 dexamethasone intravitreal implants and 1 ranibizumab intravitreal injection after a bilateral postoperative complication of cataract surgery as pseudophakic cystoid macular edema. Patients and Methods: A 70-year-old male patient with systemic hypertension developed a progressive cystoid macular edema (CME) in both eyes starting between 10 and 20 days after cataract surgery. Two intravitreal dexamethasone implants and 1 ranibizumab injection were administered; first in the right eye (RE) and then in the left eye (LE). The patient was checked for 1 whole week and then once a month for 5 months after the injections. Results: One month after the first dexamethasone implant in his RE, the spectral domain optical coherence tomography (SD-OCT) showed a progressive reduction of the foveal thickness until a complete resolution of the CME occurred, which was associated with an improvement of visual acuity. After 3 months, the SD-OCT showed a relapse of the CME, which was then treated with 1 injection of ranibizumab. One month after this injection, there was a complete resolution of the CME. A new CME in his RE was diagnosed 2 months after the last ranibizumab injection; it was treated with a new dexamethasone implant. A complete resolution of the CME was obtained; a normal foveal profile was still present 5 months after the last injection, and the best-corrected visual acuity was 20/20. His LE developed a CME 40 days after surgery. One intravitreal injection of ranibizumab was first administered in his LE, with a complete resolution of the CME at SD-OCT 2 weeks later. As observed in his RE, 40 days after the ranibizumab injection, there was a relapse of the CME that was treated with 1 intravitreal injection of dexamethasone implant. Five months later, the patient showed a worsening of the CME, but it was completely resolved with a second dexamethasone injection. After 3 months, the foveal thickness was back to normal with a BCVA of 20/20. Conclusion: Treatment with dexamethasone implants (Ozurdex®) and ranibizumab injections (Lucentis®) induced a progressive reduction of our patient's CME after cataract surgery (Irvine-Gass syndrome) until a complete normal foveal thickness was restored and his visual function was improved despite the order of injections.
- Published
- 2014
- Full Text
- View/download PDF
10. Correction to: Multimodal treatment of pediatric patients with Askin’s tumors: our experience
- Author
-
Silvia Triarico, Giorgio Attinà, Palma Maurizi, Stefano Mastrangelo, Lorenzo Nanni, Vito Briganti, Elisa Meacci, Stefano Margaritora, Mario Balducci, and Antonio Ruggiero
- Subjects
Surgery ,RD1-811 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
In the original article mentioned above, the name of the sixth author was wrongly mentioned as “Vincenzo Briganti” instead of “Vito Briganti”.
- Published
- 2018
- Full Text
- View/download PDF
11. The role of fractionated radiotherapy and radiosurgery in the management of patients with craniopharyngioma
- Author
-
Minniti, G., Esposito, V., Amichetti, M., and Maurizi Enrici, R.
- Published
- 2009
- Full Text
- View/download PDF
12. The ChoCO-W prospective observational global study: Does COVID-19 increase gangrenous cholecystitis?
- Author
-
Belinda De Simone, Fikri M. Abu-Zidan, Elie Chouillard, Salomone Di Saverio, Massimo Sartelli, Mauro Podda, Carlos Augusto Gomes, Ernest E. Moore, Susan J. Moug, Luca Ansaloni, Yoram Kluger, Federico Coccolini, Aitor Landaluce-Olavarria, Begoña Estraviz-Mateos, Ana Uriguen-Etxeberria, Alessio Giordano, Alfonso Palmieri Luna, Luz Adriana Hernández Amín, Adriana María Palmieri Hernández, Amanda Shabana, Zakaria Andee Dzulkarnaen, Muhammad Asyraf Othman, Mohamad Ikhwan Sani, Andrea Balla, Rosa Scaramuzzo, Pasquale Lepiane, Andrea Bottari, Fabio Staderini, Fabio Cianchi, Andrea Cavallaro, Antonio Zanghì, Alessandro Cappellani, Roberto Campagnacci, Angela Maurizi, Mario Martinotti, Annamaria Ruggieri, Asri Che Jusoh, Karim Abdul Rahman, Anis Suraya M. Zulkifli, Barbara Petronio, Belén Matías-García, Ana Quiroga-Valcárcel, Fernando Mendoza-Moreno, Boyko Atanasov, Fabio Cesare Campanile, Ilaria Vecchioni, Luca Cardinali, Grazia Travaglini, Elisa Sebastiani, Serge Chooklin, Serhii Chuklin, Pasquale Cianci, Enrico Restini, Sabino Capuzzolo, Giuseppe Currò, Rosalinda Filippo, Michele Rispoli, Daniel Aparicio-Sánchez, Virginia Durán Muñóz-Cruzado, Sandra Dios Barbeito, Samir Delibegovic, Amar Kesetovic, Diego Sasia, Felice Borghi, Giorgio Giraudo, Diego Visconti, Emanuele Doria, Mauro Santarelli, Davide Luppi, Stefano Bonilauri, Ugo Grossi, Giacomo Zanus, Alberto Sartori, Giacomo Piatto, Maurizio De Luca, Domenico Vita, Luigi Conti, Patrizio Capelli, Gaetano Maria Cattaneo, Athanasios Marinis, Styliani-Aikaterini Vederaki, Mehmet Bayrak, Yasemin Altıntas, Mustafa Yener Uzunoglu, Iskender Eren Demirbas, Yuksel Altinel, Serhat Meric, Yunus Emre Aktimur, Derya Salim Uymaz, Nail Omarov, Ibrahim Azamat, Eftychios Lostoridis, Eleni-Aikaterini Nagorni, Antonio Pujante, Gabriele Anania, Cristina Bombardini, Francesco Bagolini, Emre Gonullu, Baris Mantoglu, Recayi Capoglu, Stefano Cappato, Elena Muzio, Elif Colak, Suleyman Polat, Zehra Alan Koylu, Fatih Altintoprak, Zülfü Bayhan, Emrah Akin, Enrico Andolfi, Sulce Rezart, Jae Il Kim, Sung Won Jung, Yong Chan Shin, Octavian Enciu, Elena Adelina Toma, Fabio Medas, Gian Luigi Canu, Federico Cappellacci, Fabrizio D’Acapito, Giorgio Ercolani, Leonardo Solaini, Francesco Roscio, Federico Clerici, Roberta Gelmini, Francesco Serra, Elena Giulia Rossi, Francesco Fleres, Guglielmo Clarizia, Alessandro Spolini, Francesco Ferrara, Gabriela Nita, Jlenia Sarnari, Mahir Gachabayov, Abakar Abdullaev, Gaetano Poillucci, Gian Marco Palini, Simone Veneroni, Gianluca Garulli, Micaela Piccoli, Gianmaria Casoni Pattacini, Francesca Pecchini, Giulio Argenio, Mariano Fortunato Armellino, Giuseppe Brisinda, Silvia Tedesco, Pietro Fransvea, Giuseppe Ietto, Caterina Franchi, Giulio Carcano, Gennaro Martines, Giuseppe Trigiante, Giulia Negro, Gustavo Machain Vega, Agustín Rodríguez González, Leonardo Ojeda, Gaetano Piccolo, Andrea Bondurri, Anna Maffioli, Claudio Guerci, Boo Han Sin, Zamri Zuhdi, Azlanudin Azman, Hussam Mousa, Shadi al Bahri, Goran Augustin, Ivan Romic, Trpimir Moric, Ioannis Nikolopoulos, Jacopo Andreuccetti, Giusto Pignata, Rossella D’Alessio, Jakub Kenig, Urszula Skorus, Gustavo Pereira Fraga, Elcio Shiyoiti Hirano, Jackson Vinícius de Lima Bertuol, Arda Isik, Eray Kurnaz, Mohammad Sohail Asghar, Ameer Afzal, Ali Akbar, Taxiarchis Konstantinos Nikolouzakis, Konstantinos Lasithiotakis, Emmanuel Chrysos, Koray Das, Nazmi Özer, Ahmet Seker, Mohamed Ibrahim, Hytham K. S. Hamid, Ahmed Babiker, Konstantinos Bouliaris, George Koukoulis, Chrysoula-Christina Kolla, Andrea Lucchi, Laura Agostinelli, Antonio Taddei, Laura Fortuna, Carlotta Agostini, Leo Licari, Simona Viola, Cosimo Callari, Letizia Laface, Emmanuele Abate, Massimiliano Casati, Alessandro Anastasi, Giuseppe Canonico, Linda Gabellini, Lorenzo Tosi, Anna Guariniello, Federico Zanzi, Lovenish Bains, Larysa Sydorchuk, Oksana Iftoda, Andrii Sydorchuk, Michele Malerba, Federico Costanzo, Raffaele Galleano, Michela Monteleone, Andrea Costanzi, Carlo Riva, Maciej Walędziak, Andrzej Kwiatkowski, Łukasz Czyżykowski, Piotr Major, Marcin Strzałka, Maciej Matyja, Michal Natkaniec, Maria Rosaria Valenti, Maria Domenica Pia Di Vita, Maria Sotiropoulou, Stylianos Kapiris, Damien Massalou, Massimiliano Veroux, Alessio Volpicelli, Rossella Gioco, Matteo Uccelli, Marta Bonaldi, Stefano Olmi, Matteo Nardi, Giada Livadoti, Cristian Mesina, Theodor Viorel Dumitrescu, Mihai Calin Ciorbagiu, Michele Ammendola, Giorgio Ammerata, Roberto Romano, Mihail Slavchev, Evangelos P. Misiakos, Emmanouil Pikoulis, Dimitrios Papaconstantinou, Mohamed Elbahnasawy, Sherief Abdel-elsalam, Daniel M. Felsenreich, Julia Jedamzik, Nikolaos V. Michalopoulos, Theodoros A. Sidiropoulos, Maria Papadoliopoulou, Nicola Cillara, Antonello Deserra, Alessandro Cannavera, Ionuţ Negoi, Dimitrios Schizas, Athanasios Syllaios, Ilias Vagios, Stavros Gourgiotis, Nick Dai, Rekha Gurung, Marcus Norrey, Antonio Pesce, Carlo Vittorio Feo, Nicolo’ Fabbri, Nikolaos Machairas, Panagiotis Dorovinis, Myrto D. Keramida, Francesk Mulita, Georgios Ioannis Verras, Michail Vailas, Omer Yalkin, Nidal Iflazoglu, Direnc Yigit, Oussama Baraket, Karim Ayed, Mohamed hedi Ghalloussi, Parmenion Patias, Georgios Ntokos, Razrim Rahim, Miklosh Bala, Asaf Kedar, Robert G. Sawyer, Anna Trinh, Kelsey Miller, Ruslan Sydorchuk, Ruslan Knut, Oleksandr Plehutsa, Rumeysa Kevser Liman, Zeynep Ozkan, Saleh Abdel Kader, Sanjay Gupta, Monika Gureh, Sara Saeidi, Mohsen Aliakbarian, Amin Dalili, Tomohisa Shoko, Mitsuaki Kojima, Raira Nakamoto, Semra Demirli Atici, Gizem Kilinc Tuncer, Tayfun Kaya, Spiros G. Delis, Stefano Rossi, Biagio Picardi, Simone Rossi del Monte, Tania Triantafyllou, Dimitrios Theodorou, Tadeja Pintar, Jure Salobir, Dimitrios K. Manatakis, Nikolaos Tasis, Vasileios Acheimastos, Orestis Ioannidis, Lydia Loutzidou, Savvas Symeonidis, Tiago Correia de Sá, Mónica Rocha, Tommaso Guagni, Desiré Pantalone, Gherardo Maltinti, Vladimir Khokha, Wafaa Abdel-elsalam, Basma Ghoneim, José Antonio López-Ruiz, Yasin Kara, Syaza Zainudin, Firdaus Hayati, Nornazirah Azizan, Victoria Tan Phooi Khei, Rebecca Choy Xin Yi, Harivinthan Sellappan, Zaza Demetrashvili, Nika Lekiashvili, Ana Tvaladze, Caterina Froiio, Daniele Bernardi, Luigi Bonavina, Angeles Gil-Olarte, Sebastiano Grassia, Estela Romero-Vargas, Francesco Bianco, Andrew A. Gumbs, Agron Dogjani, Ferdinando Agresta, Andrey Litvin, Zsolt J. Balogh, George Gendrikson, Costanza Martino, Dimitrios Damaskos, Nikolaos Pararas, Andrew Kirkpatrick, Mikhail Kurtenkov, Felipe Couto Gomes, Adolfo Pisanu, Oreste Nardello, Fabrizio Gambarini, Hager Aref, Nicola de’ Angelis, Vanni Agnoletti, Antonio Biondi, Marco Vacante, Giulia Griggio, Roberta Tutino, Marco Massani, Giovanni Bisetto, Savino Occhionorelli, Dario Andreotti, Domenico Lacavalla, Walter L. Biffl, and Fausto Catena
- Subjects
Acute cholecystitis ,Cholecystectomy ,Gangrene ,COVID-19 ,SARS-CoV-2 ,Laparoscopy ,Surgery ,RD1-811 ,Medical emergencies. Critical care. Intensive care. First aid ,RC86-88.9 - Abstract
Abstract Background The incidence of the highly morbid and potentially lethal gangrenous cholecystitis was reportedly increased during the COVID-19 pandemic. The aim of the ChoCO-W study was to compare the clinical findings and outcomes of acute cholecystitis in patients who had COVID-19 disease with those who did not. Methods Data were prospectively collected over 6 months (October 1, 2020, to April 30, 2021) with 1-month follow-up. In October 2020, Delta variant of SARS CoV-2 was isolated for the first time. Demographic and clinical data were analyzed and reported according to the STROBE guidelines. Baseline characteristics and clinical outcomes of patients who had COVID-19 were compared with those who did not. Results A total of 2893 patients, from 42 countries, 218 centers, involved, with a median age of 61.3 (SD: 17.39) years were prospectively enrolled in this study; 1481 (51%) patients were males. One hundred and eighty (6.9%) patients were COVID-19 positive, while 2412 (93.1%) were negative. Concomitant preexisting diseases including cardiovascular diseases (p
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.